Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04557449
Title Study to Test the Safety and Tolerability of PF-07220060 in Participants With Advance Solid Tumors (CDK4)
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Pfizer
Indications

prostate adenocarcinoma

liposarcoma

lung adenocarcinoma

colorectal adenocarcinoma

progesterone-receptor positive breast cancer

estrogen-receptor positive breast cancer

Advanced Solid Tumor

Therapies

Letrozole + PF-07220060

Fulvestrant + PF-07220060

PF-07220060

Age Groups: senior | adult
Covered Countries USA

Facility Status City State Zip Country Details
Smilow Cancer Hospital at Yale - New Haven Recruiting New Haven Connecticut 06510 United States Details
Smilow Cancer Hospital Phase 1 Unit Recruiting New Haven Connecticut 06511 United States Details
Brigham & Women's Hospital Recruiting Boston Massachusetts 02115 United States Details
Dana-Farber Cancer Institute (DFCI) Recruiting Boston Massachusetts 02215 United States Details
Dana-Farber Cancer Institute Recruiting Boston Massachusetts 02215 United States Details
START Midwest Recruiting Grand Rapids Michigan 49546 United States Details
Sarah Cannon Research Institute Recruiting Nashville Tennessee 37203 United States Details
Tennessee Oncology, PLLC Recruiting Nashville Tennessee 37203 United States Details
The University of Texas MD Anderson Cancer Center Recruiting Houston Texas 77030 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field